Matthew D Perlstein1, Moeed R Chohan1, Ioana L Coman1, Kevin M Antshel2, Wanda P Fremont1, Matthew H Gnirke1, Zora Kikinis3, Frank A Middleton4, Petya D Radoeva1, Martha E Shenton5, Wendy R Kates6. 1. Department of Psychiatry and Behavioral Sciences, State University of New York at Upstate Medical University, Syracuse, NY, United States. 2. Department of Psychiatry and Behavioral Sciences, State University of New York at Upstate Medical University, Syracuse, NY, United States; Department of Psychology, Syracuse University, Syracuse, NY, United States. 3. Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. 4. Department of Psychiatry and Behavioral Sciences, State University of New York at Upstate Medical University, Syracuse, NY, United States; Department of Neuroscience and Physiology, State University of New York at Upstate Medical University, Syracuse, NY, United States. 5. Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States; Clinical Neuroscience Division, Laboratory of Neuroscience, Department of Psychiatry, VA Boston Healthcare System, Harvard Medical School, Boston, MA, United States. 6. Department of Psychiatry and Behavioral Sciences, State University of New York at Upstate Medical University, Syracuse, NY, United States. Electronic address: katesw@upstate.edu.
Abstract
BACKGROUND: This study utilized diffusion tensor imaging (DTI) to analyze white matter tractography in the anterior limb of the internal capsule (ALIC), fornix, and uncinate fasciculus (UF) of individuals with 22q11.2 deletion syndrome and controls. Aberrations in these tracts have been previously associated with schizophrenia. With up to 25% of individuals with 22q11.2DS developing schizophrenia in adulthood, we hypothesized reduction in structural integrity of these tracts, including an association with prodromal symptoms of psychosis. We further predicted an association between allelic variation in a functional polymorphism of the Nogo-66 receptor gene and 22q11.2DS white matter integrity. METHODS: Tractography was conducted using fiber assignment by streamline tracking algorithm in DTI Studio. Subjects were genotyped for the rs701428 SNP of the Nogo-66 receptor gene, and assessed for presence of prodromal symptoms. RESULTS: We found significant group differences between 22q11.2DS and controls in DTI metrics for all three tracts. DTI metrics of ALIC and UF were associated with prodromal symptoms in 22q11.2DS. Further, ALIC DTI metrics were associated with allelic variation of the rs701428 SNP of the Nogo-66 receptor gene in 22q11.2DS. CONCLUSIONS: Alterations in DTI metrics suggest white matter microstructural anomalies of the ALIC, fornix, and UF in 22q11.2DS. Structural differences in ALIC appear to be associated with the Nogo-66 receptor gene, which has been linked to myelin-mediated axonal growth inhibition. Moreover, the association between psychosis symptoms and ALIC and UF metrics suggests that the Nogo-66 receptor gene may represent a susceptibility gene for psychosis through its disruption of white matter microstructure and myelin-associated axonal growth.
BACKGROUND: This study utilized diffusion tensor imaging (DTI) to analyze white matter tractography in the anterior limb of the internal capsule (ALIC), fornix, and uncinate fasciculus (UF) of individuals with 22q11.2 deletion syndrome and controls. Aberrations in these tracts have been previously associated with schizophrenia. With up to 25% of individuals with 22q11.2DS developing schizophrenia in adulthood, we hypothesized reduction in structural integrity of these tracts, including an association with prodromal symptoms of psychosis. We further predicted an association between allelic variation in a functional polymorphism of the Nogo-66 receptor gene and 22q11.2DS white matter integrity. METHODS: Tractography was conducted using fiber assignment by streamline tracking algorithm in DTI Studio. Subjects were genotyped for the rs701428 SNP of the Nogo-66 receptor gene, and assessed for presence of prodromal symptoms. RESULTS: We found significant group differences between 22q11.2DS and controls in DTI metrics for all three tracts. DTI metrics of ALIC and UF were associated with prodromal symptoms in 22q11.2DS. Further, ALIC DTI metrics were associated with allelic variation of the rs701428 SNP of the Nogo-66 receptor gene in 22q11.2DS. CONCLUSIONS: Alterations in DTI metrics suggest white matter microstructural anomalies of the ALIC, fornix, and UF in 22q11.2DS. Structural differences in ALIC appear to be associated with the Nogo-66 receptor gene, which has been linked to myelin-mediated axonal growth inhibition. Moreover, the association between psychosis symptoms and ALIC and UF metrics suggests that the Nogo-66 receptor gene may represent a susceptibility gene for psychosis through its disruption of white matter microstructure and myelin-associated axonal growth.
Authors: James J Levitt; Robert W McCarley; Chandlee C Dickey; Martina M Voglmaier; Margaret A Niznikiewicz; Larry J Seidman; Yoshio Hirayasu; Aleksandra A Ciszewski; Ron Kikinis; Ferenc A Jolesz; Martha E Shenton Journal: Am J Psychiatry Date: 2002-07 Impact factor: 18.112
Authors: Gudrun Rosenberger; Paul G Nestor; Jungsu S Oh; James J Levitt; Gordon Kindleman; Sylvain Bouix; Jennifer Fitzsimmons; Margaret Niznikiewicz; Carl-Fredrik Westin; Ron Kikinis; Robert W McCarley; Martha E Shenton; Marek Kubicki Journal: Brain Imaging Behav Date: 2012-09 Impact factor: 3.978
Authors: D S Manoach; R L Gollub; E S Benson; M M Searl; D C Goff; E Halpern; C B Saper; S L Rauch Journal: Biol Psychiatry Date: 2000-07-15 Impact factor: 13.382
Authors: Paul G Nestor; Marek Kubicki; Noriomi Kuroki; Ronald J Gurrera; Margaret Niznikiewicz; Martha E Shenton; Robert W McCarley Journal: Psychiatry Res Date: 2007-03-28 Impact factor: 3.222
Authors: Wendy R Kates; Courtney P Burnette; Brandy A Bessette; Bradley S Folley; Leslie Strunge; Ethylin W Jabs; Godfrey D Pearlson Journal: J Child Neurol Date: 2004-05 Impact factor: 1.987
Authors: T M Maynard; G T Haskell; A Z Peters; L Sikich; J A Lieberman; A-S LaMantia Journal: Proc Natl Acad Sci U S A Date: 2003-11-12 Impact factor: 11.205
Authors: Wendy R Kates; Kevin M Antshel; Wanda P Fremont; Robert J Shprintzen; Leslie A Strunge; Courtney P Burnette; Anne Marie Higgins Journal: Am J Med Genet A Date: 2007-11-15 Impact factor: 2.802
Authors: Tony J Simon; Zhongle Wu; Brian Avants; Hui Zhang; James C Gee; Glenn T Stebbins Journal: Behav Brain Funct Date: 2008-06-17 Impact factor: 3.759
Authors: Carina Heller; Saskia Steinmann; James J Levitt; Nikos Makris; Kevin M Antshel; Wanda Fremont; Ioana L Coman; Stefan R Schweinberger; Thomas Weiß; Sylvain Bouix; Marek R Kubicki; Wendy R Kates; Zora Kikinis Journal: Schizophr Res Date: 2020-10-23 Impact factor: 4.939
Authors: Wendy R Kates; Amy K Olszewski; Matthew H Gnirke; Zora Kikinis; Joshua Nelson; Kevin M Antshel; Wanda Fremont; Petya D Radoeva; Frank A Middleton; Martha E Shenton; Ioana L Coman Journal: Schizophr Res Date: 2014-07-25 Impact factor: 4.939
Authors: Zora Kikinis; Kang Ik K Cho; Ioana L Coman; Petya D Radoeva; Sylvain Bouix; Yingying Tang; Ryan Eckbo; Nikos Makris; Jun Soo Kwon; Marek Kubicki; Kevin M Antshel; Wanda Fremont; Martha E Shenton; Wendy R Kates Journal: Brain Imaging Behav Date: 2017-10 Impact factor: 3.978
Authors: Jun Mukai; Makoto Tamura; Karine Fénelon; Andrew M Rosen; Timothy J Spellman; Rujun Kang; Amy B MacDermott; Maria Karayiorgou; Joshua A Gordon; Joseph A Gogos Journal: Neuron Date: 2015-04-23 Impact factor: 17.173